B Davis Jeffrey insider trades: Plasmatech Biopharmaceuticals (PTBI) stock purchases
Trades on the price chart
Daily close, with an arrow on each day they bought or sold
Companies
Where B reports to the SEC
and 6 more companies
Open-market buys and sales
1 trade reported on SEC Form 4, newest first
| Date | Stock | Type | Shares | Price | Value | Holding | Reported |
|---|---|---|---|---|---|---|---|
| Dec 24, 2014 | PTBI | ↑ Buy | 62,500 | $4.00 | $250K | By Lake End Capital LLC | Dec 29, 2014 (5d) |
Each row is one filing's trades in one stock, summed. Shares and prices are as filed, before any later stock split.
About B Davis Jeffrey's insider trades
B Davis Jeffrey is Chief Operating Officer at Plasmatech Biopharmaceuticals (PTBI). Since Dec 24, 2014, B has reported 1 open-market purchase worth $250K and no sales on SEC Form 4. There have been no open-market trades in the last 12 months.
Their filings also include grants and awards (16 filings), other transactions (10 filings), conversions (2 filings), gifts (1 filing). These aren't open-market trades and aren't counted above.
How to read insider trades
Officers, directors and owners of more than 10% of a company must report trades in its stock on SEC Form 4, usually within two business days. Purchases with their own money are the stronger signal: insiders sell for many reasons (taxes, diversification, a house), but buy for one. See every PTBI insider trade, the latest insider trades across the market, or cluster buys, when several insiders buy the same stock within days.